A small medical device company in Redwood City is taking on Boston Scientific Corp. for allegedly infringing its patents on electrical stimulation of the spinal cord to treat chronic pain.
Nevro Corp. and its Morrison & Foerster attorneys think they have a good head start in the litigation: two decisions from the Patent Trial and Appeal Board last year rejecting Boston Scientific’s attempt to kill a key patent.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
